These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8196691)

  • 21. [A case of spinal myoclonus associated with epidural block for lumbago].
    Ogata K; Yamada T; Yoshimura T; Taniwaki T; Kira J
    Rinsho Shinkeigaku; 1999 Jun; 39(6):658-60. PubMed ID: 10502993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of essential palatal myoclonus in a 10-year-old girl with botulinum neurotoxin.
    Krause E; Leunig A; Klopstock T; Gürkov R
    Otol Neurotol; 2006 Aug; 27(5):672-5. PubMed ID: 16868515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of painful limbs/moving extremities with botulinum toxin type A injections.
    Eisa M; Singer C; Sengun C; Russel A; Jabbari B; Papapetropoulos S
    Eur Neurol; 2008; 60(2):104-6. PubMed ID: 18552499
    [No Abstract]   [Full Text] [Related]  

  • 24. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin treatment of essential palatal myoclonus tinnitus.
    Bryce GE; Morrison MD
    J Otolaryngol; 1998 Aug; 27(4):213-6. PubMed ID: 9711516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myoclonus of the abdominal muscles originated in spinal vascular malformation].
    Shibata N; Nakajima M; Hattori T; Hirayama K
    Rinsho Shinkeigaku; 1990 Feb; 30(2):189-92. PubMed ID: 2140964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gait patterns of a patient with myoclonus of a lower limb, when OFF and ON treatment with antiepileptic drugs.
    Cioni M; Iero I; Tornatore G; Cocilovo A; Belfiore A; Ferri R
    Neurol Sci; 2007 Apr; 28(2):100-3. PubMed ID: 17464474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin therapy for abductor spasmodic dysphonia.
    Woodson G; Hochstetler H; Murry T
    J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum toxin in specific pain therapy].
    Göbel H; Jost WH;
    Schmerz; 2003 Apr; 17(2):149-65. PubMed ID: 12695898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
    Brin MF; Blitzer A; Stewart C
    Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921
    [No Abstract]   [Full Text] [Related]  

  • 32. Transient erectile dysfunction associated with intramuscular injection of botulinum toxin type A.
    Papadonikolakis AS; Vekris MD; Kostas JP; Korompilias AV; Soucacos PN
    J South Orthop Assoc; 2002; 11(2):116-8. PubMed ID: 12741592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bilateral laryngeal movement disorder and synkinesia: value of botulism toxin. Apropos of a case].
    Marie JP; Navarre I; Lerosey Y; Magnier P; Dehesdin D; Andrieu Guitrancourt J
    Rev Laryngol Otol Rhinol (Bord); 1998; 119(4):261-4. PubMed ID: 9865104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin.
    Dykstra D; Ellingham C; Belfie A; Baxter T; Lee M; Voelker A
    Mov Disord; 1993; 8(1):38-42. PubMed ID: 8419806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease.
    Adler CH; Zimmerman RS; Lyons MK; Simeone F; Brin MF
    Mov Disord; 1996 Jan; 11(1):79-81. PubMed ID: 8771071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.
    Moore AP; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):813-6. PubMed ID: 1955900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of childhood myoclonus with botulinum toxin type A.
    Awaad Y; Tayem H; Elgamal A; Coyne MF
    J Child Neurol; 1999 Dec; 14(12):781-6. PubMed ID: 10614564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhythmic myoclonias including spinal myoclonus.
    Silfverskiöld BP
    Adv Neurol; 1986; 43():275-85. PubMed ID: 3946113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.